Please assess the completion status of the following clinical trial:

Trial Title: ONO-7436 Phase II Study in Japan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients age 20 years or older~2. Patients with malignant tumor who are to be intravenously administered cisplatin as a single dose of 70 mg/m2 or more in under 3 hours~3. Patients whose performance status is 0 to 2~4. Other inclusion criteria as specified in the study protocol~Exclusion Criteria:~1. In case of patients who are previously treated with cisplatin, those having no past history of vomiting as of administration of cisplatin~2. Patients who had vomiting or dry vomiting within 24 hours before the initial administration of the moderate or severe emetic chemotherapy (including cisplatin) on Day 1 of the study~3. Pregnant women, nursing women, women of child-bearing potential, women who wish to become pregnant or women using oral contraception~4. Other exclusion criteria as specified in the study protocol

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).